ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 350 filers reported holding ARGENX SE in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13,853,144 | +18.2% | 32,213 | +8.3% | 0.02% | +22.2% |
| Q1 2024 | $11,715,895 | +3.1% | 29,756 | -0.4% | 0.02% | -10.0% |
| Q4 2023 | $11,360,088 | -12.4% | 29,861 | +13.2% | 0.02% | -23.1% |
| Q3 2023 | $12,963,298 | +153.2% | 26,368 | +100.7% | 0.03% | +160.0% |
| Q2 2023 | $5,119,491 | -17.7% | 13,136 | -21.3% | 0.01% | -16.7% |
| Q1 2023 | $6,221,712 | -49.6% | 16,699 | -48.8% | 0.01% | -52.0% |
| Q4 2022 | $12,350,992 | -14.2% | 32,603 | -20.0% | 0.02% | -21.9% |
| Q3 2022 | $14,391,000 | -7.9% | 40,753 | -1.2% | 0.03% | 0.0% |
| Q2 2022 | $15,623,000 | +8.4% | 41,237 | -9.8% | 0.03% | +28.0% |
| Q1 2022 | $14,415,000 | +1.9% | 45,722 | +13.1% | 0.02% | +8.7% |
| Q4 2021 | $14,153,000 | +39.3% | 40,422 | +20.1% | 0.02% | +35.3% |
| Q3 2021 | $10,160,000 | +3.8% | 33,649 | +3.5% | 0.02% | +6.2% |
| Q2 2021 | $9,784,000 | – | 32,503 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
| Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
| Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
| MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
| AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
| EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
| INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
| Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
| DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
| Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |